In their study, Zakharova and colleagues [34] generated iPSCs from healthy donors and from two heterozygous FH patients carrying clinically characterized pathogenic LDLR variants affecting receptor trafficking and recycling. This evidence concerns the gene LDLR and familial hyperaldosteronism.